Zealand Pharma A/S | ZEAL - Current Liabilities

Stock Price
291.70
Daily Change
-2.30 -0.78%
Monthly
-20.58%
Yearly
-37.38%
Q1 Forecast
273.20

Zealand Pharma A/S reported 664.96M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 162.94M 29.56M Dec/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
Avita Medical AUD 62.68M 77K Dec/2025
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Moderna USD 1.99B 306M Dec/2025
Organon & Co USD 2.68B 117M Sep/2025
Revvity USD 1.33B 108.5M Dec/2025
Tectonic Therapeutic USD 9.67M 293K Dec/2025
Tilray USD 259.32M 8.32M Sep/2025
Viatris USD 7.09B 269.8M Dec/2025
Xeris Pharmaceuticals USD 109.57M 6.63M Dec/2025
Zealand Pharma A/S 664.96M 513.61M Dec/2025